| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.0M | +136.7% |
| Cost of Revenue | $452K | — |
| R&D Expense | $19.1M | +212.2% |
| SG&A Expense | $12.7M | +0.9% |
| Operating Income | -$39.7M | -214.7% |
| Income Tax | $0 | — |
| Net Income | -$53.3M | -606.6% |
| EPS (Basic) | -$3.21 | -3666.7% |
| EPS (Diluted) | -$3.21 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $954K | -74.8% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $2.4M | +9077.9% |
| Current Assets | $12.6M | -45.8% |
| Total Assets | $91.3M | -14.2% |
| Current Liabilities | $8.1M | -45.3% |
| Long-term Debt | $8.5M | -13.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.9M | -2.3% |
| Investing Cash Flow | -$6.5M | -278.5% |
| Financing Cash Flow | $17.6M | +56.2% |
| -3666.7% |
| Total Liabilities |
| $31.5M |
| +11.9% |
| Stockholders' Equity | $59.8M | -23.6% |